52384
The Weekly Sceptic Live The Weekly Sceptic Live The Weekly Sceptic Live
  • Log in
The Daily Sceptic
No Result
View All Result
  • Articles
  • About
  • Archive
    • ARCHIVE
    • NEWS ROUND-UPS
  • Forum
  • Donate
  • Newsletter
The Daily Sceptic
No Result
View All Result

Cheap, Safe Treatment Cuts Serious COVID-19 by 90%, Oxford Study Shows

by Will Jones
11 April 2021 4:23 PM

A study from Oxford University has confirmed the remarkable effectiveness of common asthma treatment Budesonide for treating COVID-19.

First published as a pre-print in February and now as a peer-reviewed paper in the Lancet, the STOIC phase 2 randomised study found that inhaled Budesonide given to patients with COVID-19 within seven days of symptom onset reduced the relative risk of requiring urgent care or hospitalisation by 90%. It also resulted in a quicker recovery time for those who experienced fever and other symptoms and fewer persistent symptoms after 28 days, suggesting it could help to reduce the incidence of ‘long Covid’ in those given it as an early treatment.

Budesonide is a corticosteroid used in the long-term management of asthma and chronic obstructive pulmonary disease (COPD). The study, which is supported by the Oxford Biomedical Research Centre (BRC) and AstraZeneca, involved 146 people, half of whom took 800 micrograms of the medication twice a day while half were on usual care. It was confirmed to be safe (unsurprising for an established medicine), with only five (7%) participants reporting self-limiting adverse events.

Professor Mona Bafadhel of Oxford’s Nuffield Department of Medicine, who led the trial, said: “I am heartened that a relatively safe, widely available and well studied medicine such as an inhaled steroid could have an impact on the pressures we are experiencing during the pandemic.”

The trial came into being because clinicians noted early on in the pandemic that patients with chronic respiratory disease, who are often prescribed inhaled steroids, were significantly under-represented among those admitted to hospital with COVID-19, despite the condition being a likely risk factor.

Budesonide is unusual because, unlike Vitamin D, Hydroxychloroquine and Ivermectin, it has not (yet) been (unfairly) rubbished in the mainstream press and medical literature. For those other potential treatments you can see the studies for yourself here and read a fair overview here.

If a highly effective early outpatient treatment for COVID-19 becomes available then that may change everything in terms of vaccine programmes and exit strategies. The COVID-19 vaccines are currently authorised not under ordinary marketing licences but under temporary emergency approval. This approval is conditional on there being a current medical emergency. In the EU emergency approval can only be for an “unmet medical need”, and the approval is reviewed annually. In the US there must be no “adequate, approved, and available alternatives”. In the UK a disease must be a “serious risk or potentially serious risk to human health”, though there is no requirement to review the temporary approval.

An efficacy in reducing serious disease by 90% would rival the reported efficacy of the vaccines. The trial did not include many in high risk groups such as the elderly or those with underlying conditions, but vaccine effectiveness is also reduced in these groups.

As proven effective treatments like Budesonide come online, will the Government’s case for draconian interventions and coerced vaccinations, even on its own twisted terms, fall away?

Tags: BudesonideExit strategyTreatmentsVaccines

Donate

We depend on your donations to keep this site going. Please give what you can.

Donate Today

Comment on this Article

You’ll need to set up an account to comment if you don’t already have one. We ask for a minimum donation of £5 if you'd like to make a comment or post in our Forums.

Sign Up
Previous Post

Up to 80% of Sicilians Refuse AstraZeneca Vaccine

Next Post

Britain Sees Fastest Decline in Covid Cases in the World

Subscribe
Login
Notify of
Please log in to comment

Profanity and abuse will be removed and may lead to a permanent ban.

45 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments

NEWSLETTER

View today’s newsletter

To receive our latest news in the form of a daily email, enter your details here:

 

DONATE

PODCAST

Nick Dixon and Toby Young Talk About the Attack on Kellie-Jay Keen by Trans Rights Activists, the BBC’s Perverse Insistence on Calling a Rapist “Her” and the Brutal Cancellation of Alfie Brown

by Will Jones
28 March 2023
1

LISTED ARTICLES

  • Most Read
  • Most Commented
  • Editors Picks

The Narrative in Retreat

29 March 2023
by Ramesh Thakur

Brussels Cancels Looming Ban on Internal Combustion Engine Cars – U.K. Government “Prepared to Follow Suit”

29 March 2023
by Will Jones

COVID-19 Not Responsible for “Explosion” in Heart Deaths, Major Autopsy Study Shows. “Must Be the Vaccine,” Says Top Heart Doctor

29 March 2023
by Will Jones

News Round-Up

29 March 2023
by Will Jones

The Great Food Reset Has Begun

28 March 2023
by Will Jones

News Round-Up

44

Brussels Cancels Looming Ban on Internal Combustion Engine Cars – U.K. Government “Prepared to Follow Suit”

43

The Narrative in Retreat

29

Majority of Public Unhappy with NHS for First Time, Survey Finds

26

The Bad Science Behind Sadiq Khan’s ULEZ Anti-Car Crusade

35

COVID-19 Not Responsible for “Explosion” in Heart Deaths, Major Autopsy Study Shows. “Must Be the Vaccine,” Says Top Heart Doctor

29 March 2023
by Will Jones

Findings From a New Faculty Free Speech Survey

29 March 2023
by Noah Carl

In Defence of Andrew Bridgen’s Speech to Parliament on the Risks vs Benefits of Covid Vaccination

28 March 2023
by Norman Fenton, Clare Craig, Martin Neil, Jonathan Engler and Mr Law

The Dumb Chain of Events that Brought Face Mask Tyranny to the West

28 March 2023
by Eugyppius

The Bad Science Behind Sadiq Khan’s ULEZ Anti-Car Crusade

28 March 2023
by Ben Pile

POSTS BY DATE

April 2021
M T W T F S S
 1234
567891011
12131415161718
19202122232425
2627282930  
« Mar   May »

SOCIAL LINKS

Free Speech Union
  • Home
  • About us
  • Donate
  • Privacy Policy

Facebook

Twitter

Instagram

RSS

Subscribe to our newsletter

© Skeptics Ltd.

No Result
View All Result
  • Articles
  • About
  • Archive
    • ARCHIVE
    • NEWS ROUND-UPS
  • Forum
  • Donate
  • Newsletter

© Skeptics Ltd.

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Please note: To be able to comment on our articles you'll need to be a registered donor

Already have an account?
Please click here to login Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
wpDiscuz
You are going to send email to

Move Comment